These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 28338737

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Retinol binding protein 4--a novel association with early-onset preeclampsia.
    Vaisbuch E, Romero R, Mazaki-Tovi S, Erez O, Kim SK, Chaiworapongsa T, Gotsch F, Than NG, Dong Z, Pacora P, Lamont R, Yeo L, Hassan SS, Kusanovic JP.
    J Perinat Med; 2010 Mar; 38(2):129-39. PubMed ID: 19708829
    [Abstract] [Full Text] [Related]

  • 4. Evidence of endothelial dysfunction in preeclampsia and risk of adverse pregnancy outcome.
    Powers RW, Catov JM, Bodnar LM, Gallaher MJ, Lain KY, Roberts JM.
    Reprod Sci; 2008 Apr; 15(4):374-381. PubMed ID: 18187406
    [Abstract] [Full Text] [Related]

  • 5. Associations between maternal lipid profile and pregnancy complications and perinatal outcomes: a population-based study from China.
    Jin WY, Lin SL, Hou RL, Chen XY, Han T, Jin Y, Tang L, Zhu ZW, Zhao ZY.
    BMC Pregnancy Childbirth; 2016 Mar 21; 16():60. PubMed ID: 27000102
    [Abstract] [Full Text] [Related]

  • 6. Preliminary report: Serum levels of retinol-binding protein 4 in preeclampsia.
    Stepan H, Ebert T, Schrey S, Reisenbüchler C, Blüher M, Stumvoll M, Kratzsch J, Tönnessen P, Faber R, Fasshauer M.
    Metabolism; 2009 Mar 21; 58(3):275-7. PubMed ID: 19217438
    [Abstract] [Full Text] [Related]

  • 7. Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history.
    Poon LC, Wright D, Rolnik DL, Syngelaki A, Delgado JL, Tsokaki T, Leipold G, Akolekar R, Shearing S, De Stefani L, Jani JC, Plasencia W, Evangelinakis N, Gonzalez-Vanegas O, Persico N, Nicolaides KH.
    Am J Obstet Gynecol; 2017 Nov 21; 217(5):585.e1-585.e5. PubMed ID: 28784417
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Association of increased cord blood soluble endoglin with the development of bronchopulmonary dysplasia in preterm infants with maternal preeclampsia.
    Kim DH, Shin SH, Kim EK, Kim HS.
    Pregnancy Hypertens; 2018 Jul 21; 13():148-153. PubMed ID: 30177044
    [Abstract] [Full Text] [Related]

  • 10. Mid-pregnancy circulating immune biomarkers in women with preeclampsia and normotensive controls.
    Taylor BD, Tang G, Ness RB, Olsen J, Hougaard DM, Skogstrand K, Roberts JM, Haggerty CL.
    Pregnancy Hypertens; 2016 Jan 21; 6(1):72-8. PubMed ID: 26955776
    [Abstract] [Full Text] [Related]

  • 11. Fetal and maternal angiotensin (1-7) are associated with preterm birth.
    Chen YP, Lu YP, Li J, Liu ZW, Chen WJ, Liang XJ, Chen X, Wen WR, Xiao XM, Reichetzeder C, Hocher B.
    J Hypertens; 2014 Sep 21; 32(9):1833-41. PubMed ID: 24979298
    [Abstract] [Full Text] [Related]

  • 12. Prediction of preterm birth with and without preeclampsia using mid-pregnancy immune and growth-related molecular factors and maternal characteristics.
    Jelliffe-Pawlowski LL, Rand L, Bedell B, Baer RJ, Oltman SP, Norton ME, Shaw GM, Stevenson DK, Murray JC, Ryckman KK.
    J Perinatol; 2018 Aug 21; 38(8):963-972. PubMed ID: 29795450
    [Abstract] [Full Text] [Related]

  • 13. The expression of serum sEGFR, sFlt-1, sEndoglin and PLGF in preeclampsia.
    Cui L, Shu C, Liu Z, Tong W, Cui M, Wei C, Tang JJ, Liu X, Hu J, Jiang J, He J, Zhang DY, Ye F, Li Y.
    Pregnancy Hypertens; 2018 Jul 21; 13():127-132. PubMed ID: 30177039
    [Abstract] [Full Text] [Related]

  • 14. Human chorionic gonadotropin, angiogenic factors, and preeclampsia risk: a nested case-control study.
    Asvold BO, Eskild A, Vatten LJ.
    Acta Obstet Gynecol Scand; 2014 May 21; 93(5):454-62. PubMed ID: 24575980
    [Abstract] [Full Text] [Related]

  • 15. Maternal characteristics and mid-pregnancy serum biomarkers as risk factors for subtypes of preterm birth.
    Jelliffe-Pawlowski LL, Baer RJ, Blumenfeld YJ, Ryckman KK, O'Brodovich HM, Gould JB, Druzin ML, El-Sayed YY, Lyell DJ, Stevenson DK, Shaw GM, Currier RJ.
    BJOG; 2015 Oct 21; 122(11):1484-93. PubMed ID: 26111589
    [Abstract] [Full Text] [Related]

  • 16. Maternal serum markers of lipid metabolism in relation to neonatal anthropometry.
    Boghossian NS, Mendola P, Liu A, Robledo C, Yeung EH.
    J Perinatol; 2017 Jun 21; 37(6):629-635. PubMed ID: 28333159
    [Abstract] [Full Text] [Related]

  • 17. Maternal selenium status during early gestation and risk for preterm birth.
    Rayman MP, Wijnen H, Vader H, Kooistra L, Pop V.
    CMAJ; 2011 Mar 22; 183(5):549-55. PubMed ID: 21324870
    [Abstract] [Full Text] [Related]

  • 18. Second trimester inflammatory and metabolic markers in women delivering preterm with and without preeclampsia.
    Ross KM, Baer RJ, Ryckman K, Feuer SK, Bandoli G, Chambers C, Flowers E, Liang L, Oltman S, Dunkel Schetter C, Jelliffe-Pawlowski L.
    J Perinatol; 2019 Feb 22; 39(2):314-320. PubMed ID: 30518800
    [Abstract] [Full Text] [Related]

  • 19. The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia.
    Chaiworapongsa T, Romero R, Whitten AE, Korzeniewski SJ, Chaemsaithong P, Hernandez-Andrade E, Yeo L, Hassan SS.
    J Matern Fetal Neonatal Med; 2016 Feb 22; 29(8):1214-28. PubMed ID: 26303962
    [Abstract] [Full Text] [Related]

  • 20. Glycogen phosphorylase isoenzyme BB plasma concentration is elevated in pregnancy and preterm preeclampsia.
    Lee J, Romero R, Dong Z, Lee DC, Dong Y, Mittal P, Chaiworapongsa T, Hassan SS, Kim CJ.
    Hypertension; 2012 Feb 22; 59(2):274-82. PubMed ID: 22215716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.